Simin Hu

1.2k total citations · 1 hit paper
22 papers, 860 citations indexed

About

Simin Hu is a scholar working on Genetics, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Simin Hu has authored 22 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 11 papers in Hematology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Simin Hu's work include Chronic Lymphocytic Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Acute Lymphoblastic Leukemia research (9 papers). Simin Hu is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Acute Lymphoblastic Leukemia research (9 papers). Simin Hu collaborates with scholars based in United States, China and United Kingdom. Simin Hu's co-authors include Frank G. Haluska, Victor M. Rivera, Ian W. Flinn, Jörge E. Cortes, Tim Clackson, Michael J. Mauro, Thomas O’Hare, Hagop M. Kantarjian, Michael W. Deininger and Moshe Talpaz and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Simin Hu

22 papers receiving 849 citations

Hit Papers

Ponatinib in Refractory Philadelphia Chromosome–Positive ... 2012 2026 2016 2021 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
    2012 527 citations Jörge E. Cortes, Hagop M. Kantarjian et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simin Hu United States 9 516 377 198 141 131 22 860
Noriyoshi Iriyama Japan 18 429 0.8× 293 0.8× 109 0.6× 265 1.9× 85 0.6× 83 948
Ian Parkinson United Kingdom 6 522 1.0× 440 1.2× 335 1.7× 49 0.3× 60 0.5× 8 702
Gérald Le Gac France 22 774 1.5× 678 1.8× 78 0.4× 69 0.5× 28 0.2× 58 1.3k
Sonia Carturan Italy 17 444 0.9× 295 0.8× 46 0.2× 139 1.0× 128 1.0× 44 1.2k
Hossein Sadrzadeh United States 13 239 0.5× 140 0.4× 34 0.2× 156 1.1× 56 0.4× 35 673
Barrie Woodcock United Kingdom 11 518 1.0× 637 1.7× 338 1.7× 41 0.3× 23 0.2× 22 1.1k
Atsushi Oyama Japan 21 73 0.1× 128 0.3× 57 0.3× 312 2.2× 20 0.2× 73 1.0k
Michael G. Chen United States 14 146 0.3× 159 0.4× 60 0.3× 176 1.2× 24 0.2× 25 930
Benedikt Schaefer Austria 19 481 0.9× 301 0.8× 48 0.2× 441 3.1× 11 0.1× 44 1.3k
Jeong Hae Kie South Korea 16 104 0.2× 48 0.1× 128 0.6× 65 0.5× 14 0.1× 56 788

Countries citing papers authored by Simin Hu

Since Specialization
Citations

This map shows the geographic impact of Simin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simin Hu more than expected).

Fields of papers citing papers by Simin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simin Hu. The network helps show where Simin Hu may publish in the future.

Co-authorship network of co-authors of Simin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Simin Hu. A scholar is included among the top collaborators of Simin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simin Hu. Simin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Simin, Yu Liu, Lezhang Wei, et al.. (2024). Remediation of thallium-contaminated groundwater using magnetic illite–biochar: Structural characteristics, performance and mechanisms. Journal of environmental chemical engineering. 13(1). 115106–115106. 3 indexed citations
2.
Hu, Simin, Yu Liu, Lezhang Wei, et al.. (2024). Recent advances in clay minerals for groundwater pollution control and remediation. Environmental Science and Pollution Research. 31(17). 24724–24744. 5 indexed citations
3.
Liu, Yu, Song Wang, Simin Hu, et al.. (2023). Hydrogeochemical evolution of groundwater impacted by acid mine drainage (AMD) from polymetallic mining areas (South China). Journal of Contaminant Hydrology. 259. 104254–104254. 10 indexed citations
4.
Liu, Yu, Lezhang Wei, Hongmei Deng, et al.. (2023). Hydrogeochemistry of groundwater surrounding a pyrite mine in southern China: Assessment of the diffusive gradients in thin films technique for in situ monitoring. Journal of Hydrology. 622. 129685–129685. 13 indexed citations
5.
Hu, Simin, Qifeng Zhu, Fangfang Li, et al.. (2023). Genetic structure of giant pandas across patchily distributed habitats in the Qinling Mountains. Global Ecology and Conservation. 48. e02666–e02666. 1 indexed citations
6.
Hu, Simin, Xiaolei Li, Xianyu Meng, et al.. (2022). Detection of composition of functional component theabrownins in Pu-erh tea by degradation method. Food Science and Human Wellness. 11(3). 643–647. 20 indexed citations
7.
Chen, Dong, Ximing Zhang, Qifeng Zhu, et al.. (2022). Giant panda habitat restoration requires more than just planting bamboo and trees. Restoration Ecology. 31(4). 2 indexed citations
8.
Jankú, Filip, Albiruni R. Abdul Razak, Ping Chi, et al.. (2020). Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib. Journal of Clinical Oncology. 38(28). 3294–3303. 70 indexed citations
9.
Kocoshis, Samuel A., Russell J. Merritt, Susan Hill, et al.. (2019). Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III Study. Journal of Parenteral and Enteral Nutrition. 44(4). 621–631. 86 indexed citations
10.
Chi, Ping, Filip Jankú, Michael C. Heinrich, et al.. (2019). Abstract C077: Updated results of phase 1 study of ripretinib (DCC-2618), a broad-spectrum KIT and PDGFRA inhibitor, in patients with gastrointestinal stromal tumor (GIST) by line of therapy (NCT02571036). Molecular Cancer Therapeutics. 18(12_Supplement). C077–C077. 3 indexed citations
11.
Talpaz, Moshe, Jörge E. Cortes, Hagop M. Kantarjian, et al.. (2015). Four-year minimum follow-up of ongoing patients (pts) with chronic-phase chronic myeloid leukemia (CP-CML) in a phase 1 trial of ponatinib (PON).. Journal of Clinical Oncology. 33(15_suppl). 7047–7047. 6 indexed citations
12.
Mauro, Michael J., Jörge E. Cortes, Hagop M. Kantarjian, et al.. (2014). Safety and Durability of Ponatinib in Patients With Philadelphia Chromosome–Positive (Ph+) Leukemia: Long-term Follow-up of an Ongoing Phase 1 Study. Clinical Lymphoma Myeloma & Leukemia. 14. S137–S138. 1 indexed citations
13.
Talpaz, Moshe, Jörge E. Cortes, Hagop M. Kantarjian, et al.. (2014). Longer-term follow up of a phase 1 study of ponatinib in patients (pts) with Philadelphia chromosome-positive (Ph+) leukemias.. Journal of Clinical Oncology. 32(15_suppl). 7078–7078. 5 indexed citations
14.
Kyo, Taiichi, Arinobu Tojo, Kazuhito Yamamoto, et al.. (2014). Ponatinib Safety and Efficacy in Japanese Patients with Philadelphia Positive Leukemia: Update of a Phase 1/2 Study. Blood. 124(21). 5541–5541. 1 indexed citations
15.
Mauro, Michael J., Jörge E. Cortes, Hagop M. Kantarjian, et al.. (2013). Safety and durability of ponatinib in patients with Philadelphia chromosome-positive (Ph+) leukemia: Long-term follow-up of an ongoing phase I study.. Journal of Clinical Oncology. 31(15_suppl). 7063–7063. 3 indexed citations
16.
Cortes, Jörge E., Hagop M. Kantarjian, Neil P. Shah, et al.. (2012). Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias. New England Journal of Medicine. 367(22). 2075–2088. 527 indexed citations breakdown →
17.
Deininger, Michael W., Jörge E. Cortes, Hagop M. Kantarjian, et al.. (2012). Long-Term Anti-Leukemic Activity of Ponatinib in Patients with Philadelphia Chromosome-Positive Leukemia: Updated Results from an Ongoing Phase 1 Study. Blood. 120(21). 3743–3743. 2 indexed citations
18.
Cortes, Jörge E., Hagop M. Kantarjian, Neil P. Shah, et al.. (2011). Subset Analysis of Response to Treatment of Chronic Phase CML in a Phase 1 Study of Ponatinib in Refractory Hematologic Malignancies. Blood. 118(21). 602–602. 7 indexed citations
19.
Richards, Donald, David Loesch, Svetislava J. Vukelja, et al.. (2010). Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer. Investigational New Drugs. 29(5). 963–970. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriyoshi Iriyama Breakdown of academic impact, for papers by Ian Parkinson Breakdown of academic impact, for papers by Gérald Le Gac Breakdown of academic impact, for papers by Sonia Carturan Breakdown of academic impact, for papers by Hossein Sadrzadeh Breakdown of academic impact, for papers by Barrie Woodcock Breakdown of academic impact, for papers by Atsushi Oyama Breakdown of academic impact, for papers by Michael G. Chen Breakdown of academic impact, for papers by Benedikt Schaefer Breakdown of academic impact, for papers by Jeong Hae Kie
Rankless by CCL
2026